TRABD2A and hepatocellular carcinoma: In this research, we developed a novel risk score system consisting of ANGPT4, AMFR, COLEC12, FAM78B, LMTK3, and TRABD2A, which has the ability to accurately predict the probability of LR in HCC patients.